Dose Tracking Copilot Global Market Report 2025

The dose tracking copilot market size has grown rapidly in recent years. It will grow from $1.16 billion in 2024 to $1.36 billion in 2025 at a compound annual growth rate (CAGR) of 17.4%. Growth in the historic period can be attributed to the rising adoption of digital health tools, increased use of telemedicine, growing awareness of medication adherence, an expanding chronic disease patient base, and greater smartphone penetration.

The dose tracking copilot market size is expected to see rapid growth in the next few years. It will grow to $2.56 billion in 2029 at a compound annual growth rate (CAGR) of 17.1%. Growth in the forecast period can be linked to a strengthened focus on personalized medicine, rising demand for patient safety solutions, the expansion of cloud-based dose tracking platforms, increasing healthcare digitization, and the growing prevalence of chronic diseases. Key trends expected in the forecast period include technological advancements in dose tracking software, innovations in wearable and connected devices, developments in AI-powered adherence monitoring, research and progress in smart dosing systems, and advancements in mobile health applications.

The increasing prevalence of chronic diseases is expected to propel the growth of the dose tracking copilot market going forward. Chronic diseases are long-lasting health conditions that usually progress slowly over time, such as diabetes, heart disease, and arthritis, and often require ongoing medical attention and lifestyle management to control symptoms and prevent complications. Chronic diseases are rising largely due to unhealthy lifestyles, including poor diet, physical inactivity, and smoking, which increase the risk of conditions such as diabetes, heart disease, and obesity. Dose tracking copilot supports chronic disease management by providing real-time monitoring and personalized dose reminders, making it suitable for patients with complex medication schedules. It reduces the risk of missed or incorrect doses by enabling accurate adherence tracking, improving treatment effectiveness and overall patient outcomes. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the increasing prevalence of chronic diseases is driving the growth of the dose tracking copilot market.

The rising adoption of electronic health records (EHRs) is expected to propel the growth of the dose tracking copilot market going forward. Electronic health records are digital versions of patients’ medical histories, including diagnoses, treatments, lab results, and medications, stored securely and accessible to authorized healthcare providers. The adoption of electronic health records is increasing primarily due to the growing emphasis on digitization in healthcare, which enhances efficiency, reduces errors, and enables seamless sharing of patient information among providers. Dose tracking copilot integrates with electronic health records by enabling seamless sharing of patient medication data, making it beneficial for healthcare providers managing multiple patients. It reduces manual data entry and improves accuracy by automatically syncing dosing information, enhancing clinical decision-making and overall patient care. For instance, in June 2022, according to the Department of Health and Social Care, a UK-based government department, approximately 90% of NHS trusts had adopted electronic health records by December 2023 and were expected to reach 100% adoption by March 2025. Therefore, the rising adoption of electronic health records is driving the growth of the dose tracking copilot market.

The rising healthcare expenditure is expected to propel the growth of the dose tracking copilot market going forward. Healthcare expenditure refers to the total amount of financial resources spent on healthcare services, including medical treatments, hospital care, medications, and public health initiatives, by governments, businesses, and individuals. The increasing healthcare expenditure is due to the rising prevalence of chronic diseases, which require long-term and costly treatments. Rising healthcare expenditure supports dose tracking copilot by driving investment in digital health solutions, making advanced medication management tools more accessible. These tools reduce the risk of medication errors and improve patient outcomes by enabling precise dose monitoring, supporting overall healthcare efficiency. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure saw a 5.6% increase in nominal terms in 2023, with a 0.9% growth compared to 2022. Therefore, the rising healthcare expenditure is driving the growth of the dose tracking copilot market.

Major companies operating in the dose tracking copilot market are Johnson & Johnson, Medtronic plc, AptarGroup Inc., Inovalon Holdings Inc., WellSky Corp, QURE.AI Technologies Private Limited, House Rx Inc., Medisafe Inc, Hero Health Inc, smartpatient GmbH, PrimeRx Inc., etectRx Inc., SMRxT Inc., AiCure Inc., Robrady Inc., Adherium Limited, Intent Solutions, Medikyu, Pill Connect Limited, DoseSmart Inc.

North America was the largest region in the dose tracking copilot market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in dose tracking copilot report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the dose tracking copilot market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The dose tracking copilot market research report is one of a series of new reports that provides dose tracking copilot market statistics, including dose tracking copilot industry global market size, regional shares, competitors with a dose tracking copilot market share, detailed dose tracking copilot market segments, market trends and opportunities, and any further data you may need to thrive in the dose tracking copilot industry. This dose tracking copilot market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A dose tracking copilot refers to a digital health tool designed to support individuals or patients in accurately managing and monitoring their medication intake. It functions as an intelligent assistant that records doses, sends reminders, and helps maintain adherence to prescribed schedules. The copilot often evaluates usage patterns, notifies users of missed or incorrect doses, and can connect with wearables or smart devices for real-time tracking. It may also document symptoms or side effects, enabling users and healthcare providers to make informed decisions.

The key components of a dose tracking copilot include software, hardware, and services. Software refers to digital platforms and applications that track, monitor, and manage patient doses, offer analytics, integrate with healthcare systems, and support clinical decision-making and compliance. It is deployed through on-premises and cloud-based modes and is used in radiology, nuclear medicine, oncology, cardiology, and other fields. Key end-users include hospitals, diagnostic centers, ambulatory surgical centers, research institutes, and others.

The dose tracking copilot market consists of revenues earned by entities by providing services such as digital medication tracking, dose scheduling and reminders, real-time adherence monitoring, patient data analytics, personalized dosing recommendations, and integration with healthcare provider systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The dose tracking copilot market also includes sales of medication reminder apps, pill reminder devices, dose logging software sales, dose monitoring wearables, and digital medication logbooks. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.